The Anti-Filarial Antibodies Prevalence after Mass  Drug Administration in Two Endemic Areas of  Indonesia

Helena  Ullyartha Pangaribuan; Nungki  Hapsari Suryaningtyas; Sunarno Sunarno

Helena Ullyartha Pangaribuan Doctoral Program of Biomedical Science, Faculty of Medicine, Indonesia University, Jakarta, Indonesia, National Research and Innovation Agency, Jakarta, Indonesia.
Nungki Hapsari Suryaningtyas National Research and Innovation Agency, Jakarta, Indonesia.
Sunarno National Research and Innovation Agency, Jakarta, Indonesia.

Keywords: Lymphatic Filariasis, enzyme-linked immunosorbent assays (ELISA), antibodies, Indonesia

Abstract

Introduction: Lymphatic filariasis is a public health problem in Indonesia, and efforts to eliminate it began in 2006 in Belitung and in 2007 in Pekalongan City. It is endemic to LF, and MDA treatment has been
implemented. The study’s goal is to find antifilarial IgG4 antibodies in the community after a lot of drug treatment for filariasis in places where Brugia malayi is common, like Belitung district, Kepulauan Bangka Belitung, and Pekalongan city, Central Java, where Wuchereria bancrofti is common.
Method: We will conduct this study using serum-stored biological material and immunological techniques such as enzyme-linked immunosorbent assays (ELISA). Using ELISA, we examined a total of196 serum samples in Belitung and 140 serum samples in Pekalongan.
Results: The study results showed that the antibody prevalence in Belitung was 33.1% (665 out of 196) and 1.43% (2 out of 140). This study discovered a high prevalence of filariasis in children in Brugia-endemic
communities. However, the study found lower rates of Bancroftian infection compared to adult communities.
Conclusion: In Lassar, children still have a high prevalence of antibodies. In Gemar, the prevalence of antibodies tends to be low across all age groups. The Bm14 antibody test is a promising method for seroepidemiology. We recommend further research to identify suitable populations for transmission assessments.

How to cite this article:
Pangaribuan H U, Suryaningtyas N H, Sunarno.
Anti-Filarial Antibodies Prevalence after Mass
Drug Administration in Two Endemic Areas of
Indonesia. J Commun Dis. 2024;56(3): 10-16.

DOI: https://doi.org/10.24321/0019.5138.202443

References

Nutman TB. Filarial infections [Internet]. Fifth ed. In: Schwartz E, editor. Tropical diseases in travelers.

Elsevier Inc.; 2010 [cited 2024 Jan 11]. p. 243-53. Available from: http://dx.doi.org/10.1016/B978-0-

-37506-1.00047-7

Centers for Disease Control and Prevention [Internet]. Lymphatic filariasis; 2019 [cited 2024 Jan 3]. Available

from: https://www.cdc.gov/dpdx/lymphaticfilariasis/index.html

Nanduri J, Kazura JW. Clinical and laboratory aspects of filariasis. Clin Microbiol Rev. 1989;2(1):39-50. [PubMed]

[Google Scholar]

World Health Organization [Internet]. Lymphatic filariasis. WHO; 2020 [cited 2023 May 24]. Available

from: who.int/news-room/questions-and-answers/item/lymphatic-filariasis#:~:text=An%20estimated%20

%20million%20people%20in%20tropical%20and,37%25%20live%20in%20the%20African%20

Region%20%2835%20countries%29.

World Health Organization [Internet]. Lymphatic filariasis. 2023 [cited 2024 Mar 10]. Available from:

https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis

Ministry of Health of the Republic of Indonesia. Peraturan Menteri Kesehatan Republik Indonesia

Nomor 94 tahun 2014, tentang Penanggulangan Filariasis. 94 Tahun 2014 Jakarta; 2014. p. 1-118.

Indonesian.

Santoso, Yahya, Supranelfy Y, Suryaningtyas NH, Taviv Y, Yenni A, Arisanti M, Mayasari R, Mahdalena V,

Nurmaliani R, Marini, Krishnamoorthy K, Pangaribuan HU. Risk of recrudescence of lymphatic filariasis after

post-MDA surveillance in Brugia malayi endemic Belitung District, Indonesia. Korean J Parasitol. 2020;58(6):627-34. [PubMed] [Google Scholar]

Ramadhani T. Filariasis limfatik di kelurahan Pabean ukota Pekalongan. Kesmas. 2008;3(2):51. Indonesian.

[Google Scholar]

Ramadhani T, Ikawati B, Isnani T, Kesuma AP. [Epidemiological assessment of lymphatic filariasis in

Pekalongan City, Central Java, Indonesian]. BALABA. 2023;18(2):103-10. Indonesian. [Google Scholar]

Pekalongan City Health Office [Internet]. Profil Kesehatan Kota Pekalongan Tahun 2019; 2020

[cited 2024 Mar 16]. Available from: https://dinkes.pekalongankota.go.id/halaman/profil-kesehatan-kotapekalongan.html. Indonesian.

King JD, Jacobson J, Krentel A. Accelerating the uptake of WHO recommendations for mass drug administration using ivermectin, diethylcarbamazine, and albendazole. Am J Trop Med Hyg.2022;106(5_Suppl):26-8. [PubMed] [Google Scholar]

World Health Organization Indonesia [Internet]. One step closer to elimination: assessing the impact of mass

drug administration for lymphatic filariasis; 2024 Jan

[cited 2024 Feb 21]. Available from: https://www.who.int/indonesia/news/detail/11-01-2024-one-stepcloser-to-elimination--assessing-the-impact-of-massdrug-administration-for-lymphatic-filariasis

World Health Organisation [Internet]. Control of neglected tropical diseases; 2024 [cited 2024 Mar

. Available from: https://www.who.int/teams/control-of-neglected-tropicaldiseases/lymphaticfilariasis/diagnosis-and-treatment#:~:text=Circulating microfilariae can be detected,the periodicity of the microfilariae

Putri DF. Deteksi IgG4 antifilaria menggunakan antigen rekombinan Bm14 untuk diagnosis filariasis limfatik di Indonesia. J Ilmu Kedokt Dan Kesehat. 2019;5(4):294-304. Indonesian. [Google Scholar]

Lemeshow S, Hosmer DW, Klar J, Lwanga SK, Pramono D, Kusnanto H. Besar sampel dalam penelitian kesehatan [Internet]. Yogyakarta: Gadjah Mada University Press; 1977 [cited 2024 Mar 18]. Available from: https://lib.fkm.ui.ac.id/detail?id=4698&lokasi=lokal. Indonesian.

Ikawati B, Wijayanti T. Pengetahuan, Sikap dan perilaku masyarakat kelurahan Pabean, kecamatan Pekalongan utara, kota Pekalongan tentang filariasis limfatik. Igarss. 2014;6(1):1-5. Indonesian. [Google Scholar]

Restrepo AM, Gass K, Won KY, Sheel M, Robinson K, Graves PM, Fuimaono S, Lau CL. Potential use

of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post–mass drug administration surveillance in American Samoa. Int J Infect Dis [Internet]. 2022 [cited 2024 Mar 14];117:378-

Available from: https://doi.org/10.1016/j.ijid.2022.02.006. [PubMed] [Google Scholar]

Weil GJ, Ramzy RM, El Setouhy M, Kandil AM, Ahmed ES, Faris R. A longitudinal study of Bancroftian filariasis

in the Nile Delta of Egypt: baseline data and oneyear follow-up. Am J Trop Med Hyg. 1999;61(1):53-8.

[PubMed] [Google Scholar]

Lammie PJ, Weil G, Noordin R, Kaliraj P, Steel C, Goodman D, Lakshmikanthan VB, Ottesen E.

Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis -

a multicenter trial. Filaria J. 2004;3(1):9. [PubMed] [Google Scholar]

Joseph H, Maiava F, Naseri T, Taleo F, Ake M, Capuano C, Melrose W. Application of the filariasis CELISA

antifilarial IgG(4) antibody assay in surveillance in lymphatic filariasis elimination programmes in the South Pacific. J Trop Med. 2011;2011:492023. [PubMed] [Google Scholar]

Dylewski JS, Rasmussen L, Mills J, Merigan TC. Largescale serological screening for cytomegalovirus

antibodies in homosexual males by enzyme-linked immunosorbent assay. J Clin Microbiol. 1984;19(2):200-3. [PubMed] [Google Scholar]

Aboagye IF, Addison YA. The impact of mass drug administration on lymphatic filariasis. J Trop Med.

;2022:7504871. [Google Scholar]